Australia markets close in 3 hours 27 minutes

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.48+0.01 (+0.13%)
At close: 04:00PM EDT
7.48 -0.02 (-0.32%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 69.98M
Enterprise value 56.19M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.01k
Price/book (mrq)6.08
Enterprise value/revenue 8.03k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 389.66%
S&P500 52-week change 323.23%
52-week high 310.70
52-week low 31.86
50-day moving average 37.57
200-day moving average 34.53

Share statistics

Avg vol (3-month) 392.08k
Avg vol (10-day) 334.69k
Shares outstanding 59.37M
Implied shares outstanding 69.37M
Float 86.01M
% held by insiders 19.28%
% held by institutions 165.70%
Shares short (15 May 2024) 456.14k
Short ratio (15 May 2024) 40.28
Short % of float (15 May 2024) 40.65%
Short % of shares outstanding (15 May 2024) 40.60%
Shares short (prior month 15 Apr 2024) 412.22k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 326 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-307,028.56%

Management effectiveness

Return on assets (ttm)-115.70%
Return on equity (ttm)-267.59%

Income statement

Revenue (ttm)7k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -21.41M
Net income avi to common (ttm)-21.69M
Diluted EPS (ttm)-235.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.14M
Total cash per share (mrq)1.51
Total debt (mrq)354k
Total debt/equity (mrq)3.08%
Current ratio (mrq)4.18
Book value per share (mrq)4.22

Cash flow statement

Operating cash flow (ttm)-20.2M
Levered free cash flow (ttm)-11.91M